Analysts’ price target changes for Tuesday, November 10th:
AAON (NASDAQ:AAON) had its price target cut by Robert W. Baird from $110.00 to $104.00. The firm currently has an outperform rating on the stock.
AbCellera Biologics (NASDAQ:ABCL) had its target price raised by Stifel Nicolaus from $9.00 to $14.00. They currently have a buy rating on the stock.
AB Dynamics (LON:ABDP) had its price target cut by Berenberg Bank from GBX 1,700 to GBX 1,350. The firm currently has a buy rating on the stock.
Archer Aviation (NYSE:ACHR) had its price target trimmed by Needham & Company LLC from $9.00 to $7.00. Needham & Company LLC currently has a buy rating on the stock.
Archer Aviation (NYSE:ACHR) had its target price reduced by Cantor Fitzgerald from $11.00 to $10.00. They currently have an overweight rating on the stock.
Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by Guggenheim from $32.00 to $34.00. Guggenheim currently has a buy rating on the stock.
Allstate (NYSE:ALL) had its target price raised by Keefe, Bruyette & Woods from $232.00 to $241.00. The firm currently has an underperform rating on the stock.
Allstate (NYSE:ALL) had its price target raised by Morgan Stanley from $240.00 to $260.00. Morgan Stanley currently has an equal weight rating on the stock.
Antero Midstream (NYSE:AM) had its target price lowered by Morgan Stanley from $26.00 to $24.00. They currently have an equal weight rating on the stock.
Affiliated Managers Group (NYSE:AMG) had its price target increased by TD Cowen from $523.00 to $583.00. They currently have a buy rating on the stock.
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its target price raised by Mizuho from $38.00 to $39.00. The firm currently has an outperform rating on the stock.
American Public Education (NASDAQ:APEI) had its price target raised by B. Riley Financial from $65.00 to $68.00. The firm currently has a buy rating on the stock.
Apple Hospitality REIT (NYSE:APLE) had its target price increased by Cantor Fitzgerald from $18.00 to $22.00. The firm currently has an overweight rating on the stock.
Arcos Dorados (NYSE:ARCO) had its target price cut by JPMorgan Chase & Co. from $10.50 to $10.00. The firm currently has an overweight rating on the stock.
Arhaus (NASDAQ:ARHS) had its price target boosted by Guggenheim from $12.00 to $17.00. The firm currently has a buy rating on the stock.
AerSale (NASDAQ:ASLE) had its target price cut by Royal Bank Of Canada from $7.00 to $6.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
AST SpaceMobile (NASDAQ:ASTS) had its target price trimmed by B. Riley Financial from $65.00 to $48.00. They currently have a neutral rating on the stock.
Atlanticus (NASDAQ:ATLC) had its target price increased by Citizens Jmp from $110.00 to $117.00. They currently have a market outperform rating on the stock.
Attovia Therapeutics (NASDAQ:ATTO) had its target price boosted by Morgan Stanley from $39.00 to $40.00. The firm currently has an overweight rating on the stock.
ArriVent BioPharma (NASDAQ:AVBP) had its target price raised by Truist Financial from $21.00 to $24.00. The firm currently has a buy rating on the stock.
Barrick Mining (NYSE:B) (TSE:ABX) had its price target trimmed by JPMorgan Chase & Co. from $55.00 to $53.00. They currently have an overweight rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its price target reduced by Morgan Stanley from $41.00 to $30.00. Morgan Stanley currently has an overweight rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its price target cut by BTIG Research from $39.00 to $37.00. They currently have a buy rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its target price cut by Stifel Nicolaus from $45.00 to $43.00. The firm currently has a buy rating on the stock.
Becton, Dickinson and Company (NYSE:BDX) had its target price boosted by Barclays from $165.00 to $195.00. The firm currently has an underweight rating on the stock.
Better Home & Finance (NASDAQ:BETR) had its price target reduced by B. Riley Financial from $26.00 to $23.00. B. Riley Financial currently has a buy rating on the stock.
Brookdale Senior Living (NYSE:BKD) had its price target lowered by Barclays from $17.00 to $14.00. Barclays currently has an overweight rating on the stock.
Billiontoone (NASDAQ:BLLN) had its price target lowered by Piper Sandler from $140.00 to $130.00. The firm currently has an overweight rating on the stock.
Brookfield (NYSE:BN) had its price target boosted by JPMorgan Chase & Co. from $56.00 to $65.00. The firm currently has an overweight rating on the stock.
BTGO (NYSE:BTGO) had its price target trimmed by Canaccord Genuity Group from $15.00 to $12.00. They currently have a buy rating on the stock.
BTGO (NYSE:BTGO) had its target price trimmed by Rosenblatt Securities from $10.00 to $9.00. They currently have a buy rating on the stock.
BTGO (NYSE:BTGO) had its target price cut by Wells Fargo & Company from $11.00 to $9.00. Wells Fargo & Company currently has an overweight rating on the stock.
Babcock (NYSE:BW) had its target price cut by Needham & Company LLC from $20.00 to $15.00. Needham & Company LLC currently has a buy rating on the stock.
Blackstone Secured Lending Fund (NYSE:BXSL) had its price target cut by B. Riley Financial from $23.50 to $22.50. B. Riley Financial currently has a neutral rating on the stock.
Cardinal Health (NYSE:CAH) had its price target boosted by JPMorgan Chase & Co. from $260.00 to $286.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Caris Life Sciences (NASDAQ:CAI) had its price target increased by Piper Sandler from $22.00 to $25.00. They currently have a neutral rating on the stock.
Cabot (NYSE:CBT) had its target price cut by JPMorgan Chase & Co. from $78.00 to $68.00. They currently have an underweight rating on the stock.
CECO Environmental (TXSE:CECO) had its price target boosted by JPMorgan Chase & Co. from $110.00 to $120.00. They currently have an overweight rating on the stock.
Ceva (NASDAQ:CEVA) had its price target lowered by JPMorgan Chase & Co. from $45.00 to $35.00. The firm currently has a neutral rating on the stock.
Ceva (NASDAQ:CEVA) had its target price reduced by Stifel Nicolaus from $50.00 to $40.00. They currently have a buy rating on the stock.
Carlyle Group (NASDAQ:CG) had its target price lowered by The Goldman Sachs Group from $66.00 to $58.00. The firm currently has a buy rating on the stock.
Clarus (NASDAQ:CLAR) had its target price boosted by B. Riley Financial from $4.50 to $6.00. The firm currently has a buy rating on the stock.
Compass Therapeutics (NASDAQ:CMPX) had its price target lowered by Wedbush from $1.00 to $0.90. Wedbush currently has a neutral rating on the stock.
CNH Industrial (NYSE:CNH) had its target price raised by Barclays from $14.00 to $15.00. Barclays currently has an overweight rating on the stock.
CNH Industrial (NYSE:CNH) had its price target raised by Robert W. Baird from $15.00 to $16.00. The firm currently has an outperform rating on the stock.
CNH Industrial (NYSE:CNH) had its price target boosted by JPMorgan Chase & Co. from $11.00 to $12.00. They currently have an underweight rating on the stock.
Cencora (NYSE:COR) had its target price raised by JPMorgan Chase & Co. from $390.00 to $413.00. The firm currently has an overweight rating on the stock.
CorMedix (NASDAQ:CRMD) had its target price raised by Royal Bank Of Canada from $14.00 to $15.00. The firm currently has an outperform rating on the stock.
CorMedix (NASDAQ:CRMD) had its target price raised by Needham & Company LLC from $12.00 to $14.00. Needham & Company LLC currently has a buy rating on the stock.
Criteo (NASDAQ:CRTO) had its price target lowered by Morgan Stanley from $25.00 to $20.00. They currently have an equal weight rating on the stock.
Csquare (NYSE:CSQR) had its price target increased by TD Cowen from $28.00 to $30.00. The firm currently has a buy rating on the stock.
Cytek Biosciences (NASDAQ:CTKB) had its target price increased by Stephens from $6.00 to $7.00. Stephens currently has an overweight rating on the stock.
Docebo (NASDAQ:DCBO) had its price target increased by Scotiabank from $25.00 to $35.00. The firm currently has a sector outperform rating on the stock.
DocGo (NASDAQ:DCGO) had its price target reduced by Needham & Company LLC to $1.00. The firm currently has a buy rating on the stock.
American Axle & Manufacturing (NYSE:DCH) had its target price cut by Stifel Nicolaus from $6.00 to $5.00. The firm currently has a hold rating on the stock.
Delcath Systems (NASDAQ:DCTH) had its target price increased by HC Wainwright from $32.00 to $36.00. The firm currently has a buy rating on the stock.
Definium Therapeutics (NASDAQ:DFTX) had its target price boosted by Royal Bank Of Canada from $66.00 to $70.00. The firm currently has an outperform rating on the stock.
Everus Construction Group (NYSE:ECG) had its price target trimmed by Cantor Fitzgerald from $152.00 to $123.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Everus Construction Group (NYSE:ECG) had its price target lowered by Stifel Nicolaus from $172.00 to $139.00. They currently have a buy rating on the stock.
e.l.f. Beauty (NYSE:ELF) had its target price increased by Morgan Stanley from $103.00 to $125.00. The firm currently has an equal weight rating on the stock.
Essex Property Trust (NYSE:ESS) had its target price boosted by Truist Financial from $286.00 to $288.00. The firm currently has a hold rating on the stock.
Energy Transfer (TXSE:ET) had its target price cut by Scotiabank from $24.00 to $23.00. They currently have a sector outperform rating on the stock.
Eton Pharmaceuticals (NASDAQ:ETON) had its target price raised by B. Riley Financial from $70.00 to $81.00. They currently have a buy rating on the stock.
Endeavour Silver (NYSE:EXK) (TSE:EDR) had its target price trimmed by HC Wainwright from $17.00 to $16.75. The firm currently has a buy rating on the stock.
Ferguson (NYSE:FERG) had its target price raised by Robert W. Baird from $288.00 to $300.00. Robert W. Baird currently has an outperform rating on the stock.
Ferguson (NYSE:FERG) had its target price increased by Barclays from $313.00 to $314.00. They currently have an overweight rating on the stock.
Ferguson (NYSE:FERG) had its target price boosted by Oppenheimer from $288.00 to $296.00. They currently have an outperform rating on the stock.
Fiserv (NASDAQ:FISV) had its target price boosted by Truist Financial from $51.00 to $65.00. They currently have a hold rating on the stock.
Fulgent Genetics (NASDAQ:FLGT) had its price target boosted by Piper Sandler from $19.00 to $25.00. They currently have a neutral rating on the stock.
Fidelity National Financial (NYSE:FNF) had its target price boosted by Keefe, Bruyette & Woods from $53.00 to $55.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Fervo Energy (NASDAQ:FRVO) had its price target lowered by Robert W. Baird from $26.00 to $20.00. The firm currently has an outperform rating on the stock.
Liberty Media Corporation – Liberty Formula One Series A (NASDAQ:FWONA) had its target price boosted by TD Cowen from $107.00 to $113.00. TD Cowen currently has a buy rating on the stock.
Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) had its target price boosted by TD Cowen from $118.00 to $125.00. The firm currently has a buy rating on the stock.
GCM Grosvenor (NASDAQ:GCMG) had its price target boosted by JPMorgan Chase & Co. from $13.00 to $14.50. The firm currently has a neutral rating on the stock.
GCM Grosvenor (NASDAQ:GCMG) had its target price raised by Piper Sandler from $14.50 to $15.00. They currently have an overweight rating on the stock.
Guardant Health (NASDAQ:GH) had its price target lowered by Piper Sandler from $193.00 to $190.00. They currently have an overweight rating on the stock.
GRAIL (NASDAQ:GRAL) had its target price increased by Piper Sandler from $74.00 to $130.00. The firm currently has a neutral rating on the stock.
Goldman Sachs BDC (NYSE:GSBD) had its price target lowered by Truist Financial from $10.00 to $9.00. Truist Financial currently has a hold rating on the stock.
Goosehead Insurance (NASDAQ:GSHD) had its price target raised by Piper Sandler from $48.00 to $56.00. The firm currently has a neutral rating on the stock.
The Hain Celestial Group (NASDAQ:HAIN) had its target price cut by Barclays from $0.30 to $0.10. They currently have an underweight rating on the stock.
Home Depot (NYSE:HD) had its price target raised by Sanford C. Bernstein from $344.00 to $357.00. They currently have a market perform rating on the stock.
Hims & Hers Health (NYSE:HIMS) had its target price reduced by Needham & Company LLC from $42.00 to $32.00. Needham & Company LLC currently has a buy rating on the stock.
Hims & Hers Health (NYSE:HIMS) had its target price cut by Morgan Stanley from $28.00 to $25.00. The firm currently has an equal weight rating on the stock.
H&R Block (NYSE:HRB) had its price target raised by The Goldman Sachs Group from $36.00 to $40.00. They currently have a sell rating on the stock.
Horizon Technology Finance (NASDAQ:HRZN) had its price target reduced by B. Riley Financial from $5.00 to $4.50. The firm currently has a neutral rating on the stock.
Host Hotels & Resorts (NASDAQ:HST) had its price target boosted by Cantor Fitzgerald from $24.00 to $27.00. The firm currently has a neutral rating on the stock.
Humana (NYSE:HUM) had its price target raised by JPMorgan Chase & Co. from $393.00 to $484.00. The firm currently has a neutral rating on the stock.
IBEX (NASDAQ:IBEX) had its target price boosted by Royal Bank Of Canada from $40.00 to $45.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Immunocore (NASDAQ:IMCR) had its price target lowered by HC Wainwright from $100.00 to $80.00. They currently have a buy rating on the stock.
Immunome (NASDAQ:IMNM) had its target price trimmed by Piper Sandler from $33.00 to $30.00. Piper Sandler currently has an overweight rating on the stock.
Immunome (NASDAQ:IMNM) had its target price cut by Stifel Nicolaus from $24.00 to $23.00. They currently have a hold rating on the stock.
Immunovant (NASDAQ:IMVT) had its price target boosted by Wells Fargo & Company from $45.00 to $47.00. They currently have an overweight rating on the stock.
Immunovant (NASDAQ:IMVT) had its price target increased by Truist Financial from $30.00 to $33.00. Truist Financial currently has a hold rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price reduced by HC Wainwright from $100.00 to $70.00. The firm currently has a buy rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price lowered by Oppenheimer from $85.00 to $70.00. Oppenheimer currently has an outperform rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price reduced by Morgan Stanley from $104.00 to $75.00. Morgan Stanley currently has an overweight rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price lowered by The Goldman Sachs Group from $58.00 to $41.00. The Goldman Sachs Group currently has a neutral rating on the stock.
JinkoSolar (NYSE:JKS) had its target price reduced by Glj Research from $12.08 to $5.27. The firm currently has a sell rating on the stock.
Kodiak Gas Services (NYSE:KGS) had its target price lowered by Stifel Nicolaus from $92.00 to $90.00. The firm currently has a buy rating on the stock.
Kodiak Gas Services (NYSE:KGS) had its price target reduced by Royal Bank Of Canada from $82.00 to $78.00. The firm currently has an outperform rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its target price boosted by Morgan Stanley from $138.00 to $140.00. Morgan Stanley currently has an overweight rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its target price cut by Oppenheimer from $163.00 to $156.00. They currently have an outperform rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its target price raised by Wells Fargo & Company from $97.00 to $105.00. They currently have an equal weight rating on the stock.
Kinetik (NYSE:KNTK) had its price target cut by Morgan Stanley from $67.00 to $64.00. They currently have an overweight rating on the stock.
Kratos Defense & Security Solutions (NASDAQ:KTOS) had its price target reduced by Barclays from $90.00 to $80.00. Barclays currently has an overweight rating on the stock.
Lucid Group (NASDAQ:LCID) had its price target trimmed by Robert W. Baird from $6.00 to $5.00. The firm currently has a neutral rating on the stock.
Lucid Group (NASDAQ:LCID) had its target price lowered by Cantor Fitzgerald from $8.00 to $6.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Lincoln Educational Services (NASDAQ:LINC) had its target price cut by Rosenblatt Securities from $50.00 to $40.00. Rosenblatt Securities currently has a buy rating on the stock.
Lincoln Educational Services (NASDAQ:LINC) had its price target lowered by B. Riley Financial from $52.00 to $50.00. B. Riley Financial currently has a buy rating on the stock.
Lumentum (NASDAQ:LITE) had its target price raised by Sanford C. Bernstein from $635.00 to $700.00. The firm currently has an outperform rating on the stock.
LENSAR (NASDAQ:LNSR) had its price target cut by BTIG Research from $10.00 to $9.00. They currently have a buy rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price boosted by Sanford C. Bernstein from $254.00 to $270.00. They currently have an outperform rating on the stock.
LPL Financial (NASDAQ:LPLA) had its target price increased by Morgan Stanley from $393.00 to $399.00. They currently have an overweight rating on the stock.
Liquidia (NASDAQ:LQDA) had its price target increased by BTIG Research from $70.00 to $87.00. The firm currently has a buy rating on the stock.
LTC Properties (NYSE:LTC) had its price target increased by Royal Bank Of Canada from $52.00 to $53.00. They currently have an outperform rating on the stock.
Live Nation Entertainment (NYSE:LYV) had its price target increased by Oppenheimer from $210.00 to $215.00. The firm currently has an outperform rating on the stock.
MARA (NASDAQ:MARA) had its price target reduced by Rosenblatt Securities from $15.00 to $11.00. Rosenblatt Securities currently has a buy rating on the stock.
Maze Therapeutics (NASDAQ:MAZE) had its price target increased by Wedbush from $48.00 to $49.00. The firm currently has an outperform rating on the stock.
McKesson (NYSE:MCK) had its price target raised by JPMorgan Chase & Co. from $1,042.00 to $1,255.00. They currently have an overweight rating on the stock.
MDA Space (NYSE:MDA) had its target price cut by JPMorgan Chase & Co. from $50.00 to $44.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
MidCap Financial Investment (NASDAQ:MFIC) had its target price raised by Royal Bank Of Canada from $10.00 to $11.00. They currently have a sector perform rating on the stock.
Martin Marietta Materials (NYSE:MLM) had its target price lowered by B. Riley Financial from $700.00 to $615.00. The firm currently has a buy rating on the stock.
monday.com (NASDAQ:MNDY) had its target price trimmed by Morgan Stanley from $115.00 to $109.00. Morgan Stanley currently has an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its price target reduced by JPMorgan Chase & Co. from $87.00 to $84.00. They currently have a neutral rating on the stock.
monday.com (NASDAQ:MNDY) had its price target lowered by Wells Fargo & Company from $120.00 to $100.00. Wells Fargo & Company currently has an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its target price trimmed by Barclays from $100.00 to $91.00. They currently have an equal weight rating on the stock.
monday.com (NASDAQ:MNDY) had its target price reduced by BTIG Research from $105.00 to $100.00. They currently have a buy rating on the stock.
Motorcar Parts of America (NASDAQ:MPAA) had its target price trimmed by Cantor Fitzgerald from $20.00 to $18.00. They currently have an overweight rating on the stock.
Mplx (NYSE:MPLX) had its target price lowered by Morgan Stanley from $64.00 to $60.00. They currently have an equal weight rating on the stock.
MSG Knickerbockers (NYSE:MSGK) had its price target trimmed by Morgan Stanley from $450.00 to $375.00. They currently have an overweight rating on the stock.
McEwen (NYSE:MUX) (TSE:MUX) had its target price lowered by HC Wainwright from $28.00 to $27.00. They currently have a buy rating on the stock.
Microvast (NASDAQ:MVST) had its target price lowered by Cantor Fitzgerald to $2.00. They currently have an overweight rating on the stock.
National Energy Services Reunited (NASDAQ:NESR) had its price target reduced by Barclays from $41.00 to $37.00. The firm currently has an overweight rating on the stock.
Neurogene (NASDAQ:NGNE) had its price target trimmed by HC Wainwright from $65.00 to $60.00. HC Wainwright currently has a buy rating on the stock.
NMI (NASDAQ:NMIH) had its price target raised by JPMorgan Chase & Co. from $45.00 to $46.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
NNN REIT (NYSE:NNN) had its target price boosted by Truist Financial from $45.00 to $46.00. The firm currently has a hold rating on the stock.
Nerdy (NYSE:NRDY) had its price target increased by Needham & Company LLC from $2.00 to $8.00. They currently have a buy rating on the stock.
NexPoint Real Estate Finance (NYSE:NREF) had its price target trimmed by Keefe, Bruyette & Woods from $15.00 to $14.00. The firm currently has a market perform rating on the stock.
NovoCure (NASDAQ:NVCR) had its target price reduced by Wedbush from $20.00 to $19.00. They currently have a neutral rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target trimmed by Wells Fargo & Company from $315.00 to $300.00. They currently have an overweight rating on the stock.
Realty Income (NYSE:O) had its target price boosted by Truist Financial from $60.00 to $63.00. Truist Financial currently has a hold rating on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its price target boosted by HC Wainwright from $25.00 to $28.00. The firm currently has a buy rating on the stock.
Onto Innovation (NYSE:ONTO) had its price target reduced by Morgan Stanley from $360.00 to $325.00. The firm currently has an overweight rating on the stock.
Onto Innovation (NYSE:ONTO) had its target price cut by Royal Bank Of Canada from $400.00 to $350.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Pebblebrook Hotel Trust (NYSE:PEB) had its target price raised by Cantor Fitzgerald from $19.00 to $23.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Park Hotels & Resorts (NYSE:PK) had its price target increased by Cantor Fitzgerald from $15.00 to $17.00. They currently have a neutral rating on the stock.
Palomar (NASDAQ:PLMR) had its target price raised by Keefe, Bruyette & Woods from $161.00 to $172.00. They currently have an outperform rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its price target increased by Wedbush from $188.00 to $189.00. The firm currently has an underperform rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its price target lowered by Wells Fargo & Company from $362.00 to $343.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its target price raised by Royal Bank Of Canada from $462.00 to $478.00. Royal Bank Of Canada currently has an outperform rating on the stock.
United Parks & Resorts (NYSE:PRKS) had its price target raised by Guggenheim from $54.00 to $56.00. Guggenheim currently has a buy rating on the stock.
Primo Brands (NYSE:PRMB) had its target price increased by JPMorgan Chase & Co. from $26.00 to $27.00. They currently have an overweight rating on the stock.
PubMatic (NASDAQ:PUBM) had its price target boosted by Royal Bank Of Canada from $20.00 to $22.00. Royal Bank Of Canada currently has an outperform rating on the stock.
PubMatic (NASDAQ:PUBM) had its price target increased by B. Riley Financial from $21.00 to $24.00. The firm currently has a buy rating on the stock.
PubMatic (NASDAQ:PUBM) had its price target raised by Rosenblatt Securities from $23.00 to $25.00. Rosenblatt Securities currently has a buy rating on the stock.
Qualys (NASDAQ:QLYS) had its target price raised by Robert W. Baird from $160.00 to $210.00. Robert W. Baird currently has a neutral rating on the stock.
Qualys (NASDAQ:QLYS) had its target price raised by Piper Sandler from $175.00 to $185.00. Piper Sandler currently has a neutral rating on the stock.
Qualys (NASDAQ:QLYS) had its price target boosted by Wedbush from $175.00 to $185.00. Wedbush currently has a neutral rating on the stock.
Qualys (NASDAQ:QLYS) had its target price trimmed by JPMorgan Chase & Co. from $241.00 to $215.00. They currently have a neutral rating on the stock.
Qualys (NASDAQ:QLYS) had its target price raised by Royal Bank Of Canada from $180.00 to $197.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Qualys (NASDAQ:QLYS) had its price target increased by Morgan Stanley from $130.00 to $140.00. The firm currently has an underweight rating on the stock.
Quantum (NASDAQ:QMCO) had its target price raised by Cantor Fitzgerald from $29.00 to $32.00. The firm currently has an overweight rating on the stock.
Quanterix (NASDAQ:QTRX) had its price target raised by TD Cowen from $3.50 to $4.00. The firm currently has a hold rating on the stock.
RB Global (NYSE:RBA) (TSE:RBA) had its price target trimmed by Royal Bank Of Canada from $152.00 to $134.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Reddit (NYSE:RDDT) had its price target trimmed by Guggenheim from $170.00 to $140.00. They currently have a buy rating on the stock.
Radian Group (NYSE:RDN) had its target price cut by Keefe, Bruyette & Woods from $44.00 to $43.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
RadNet (NASDAQ:RDNT) had its target price raised by KeyCorp from $92.00 to $95.00. They currently have an overweight rating on the stock.
Ryman Hospitality Properties (NYSE:RHP) had its price target raised by Cantor Fitzgerald from $135.00 to $152.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Rocket Lab (NASDAQ:RKLB) had its target price reduced by Piper Sandler from $83.00 to $58.00. Piper Sandler currently has a neutral rating on the stock.
Rocket Lab (NASDAQ:RKLB) had its price target lowered by Cantor Fitzgerald from $122.00 to $111.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Rocket Lab (NASDAQ:RKLB) had its target price reduced by Barclays from $85.00 to $82.00. The firm currently has an overweight rating on the stock.
Radiant Logistics (NYSEAMERICAN:RLGT) had its price target raised by Citizens Jmp from $10.00 to $11.00. They currently have a market outperform rating on the stock.
Roivant Sciences (NASDAQ:ROIV) had its target price increased by HC Wainwright from $47.00 to $48.00. The firm currently has a buy rating on the stock.
Repay (NASDAQ:RPAY) had its price target trimmed by Canaccord Genuity Group from $8.00 to $7.00. The firm currently has a buy rating on the stock.
RPM International (NYSE:RPM) had its target price raised by Royal Bank Of Canada from $120.00 to $125.00. The firm currently has an outperform rating on the stock.
Sanmina (NASDAQ:SANM) had its target price reduced by JPMorgan Chase & Co. from $270.00 to $230.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Sharplink Gaming (NASDAQ:SBET) had its price target reduced by B. Riley Financial from $14.00 to $11.00. The firm currently has a buy rating on the stock.
Vivid Seats (NASDAQ:SEAT) had its price target trimmed by Royal Bank Of Canada from $9.00 to $4.00. They currently have a sector perform rating on the stock.
Securitize (NYSE:SECZ) had its target price lowered by Rosenblatt Securities from $13.00 to $12.00. They currently have a buy rating on the stock.
Securitize (NYSE:SECZ) had its target price raised by Needham & Company LLC from $11.00 to $13.00. Needham & Company LLC currently has a buy rating on the stock.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its price target increased by Barclays from $10.00 to $11.00. They currently have an equal weight rating on the stock.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its target price boosted by TD Cowen from $15.00 to $17.00. They currently have a buy rating on the stock.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its target price raised by Mizuho from $18.00 to $20.00. Mizuho currently has an outperform rating on the stock.
Septerna (NASDAQ:SEPN) had its price target increased by Stifel Nicolaus from $49.00 to $60.00. They currently have a buy rating on the stock.
Somnigroup International (NYSE:SGI) had its price target reduced by KeyCorp from $105.00 to $100.00. They currently have an overweight rating on the stock.
Somnigroup International (NYSE:SGI) had its price target cut by Morgan Stanley from $95.00 to $90.00. The firm currently has an overweight rating on the stock.
Surgery Partners (NASDAQ:SGRY) had its target price increased by Royal Bank Of Canada from $23.50 to $25.00. The firm currently has a sector perform rating on the stock.
Shake Shack (NYSE:SHAK) had its price target boosted by JPMorgan Chase & Co. from $75.00 to $77.00. They currently have a neutral rating on the stock.
Skydance (NYSE:SKYD) had its target price increased by Wells Fargo & Company from $7.00 to $8.00. The firm currently has an underweight rating on the stock.
Skydance (NYSE:SKYD) had its price target reduced by Citizens Jmp from $14.00 to $13.00. They currently have a market outperform rating on the stock.
Surrozen (NASDAQ:SRZN) had its target price boosted by Cantor Fitzgerald from $40.00 to $62.00. The firm currently has an overweight rating on the stock.
Sun Communities (NYSE:SUI) had its price target cut by Robert W. Baird from $138.00 to $131.00. The firm currently has a neutral rating on the stock.
Skyworks Solutions (NASDAQ:SWKS) had its target price increased by JPMorgan Chase & Co. from $65.00 to $77.00. The firm currently has a neutral rating on the stock.
Telos (NASDAQ:TLS) had its price target raised by B. Riley Financial from $9.00 to $11.00. The firm currently has a buy rating on the stock.
Telos (NASDAQ:TLS) had its target price boosted by Needham & Company LLC from $6.00 to $9.00. The firm currently has a buy rating on the stock.
Telos (NASDAQ:TLS) had its price target boosted by Wedbush from $5.00 to $7.00. The firm currently has a neutral rating on the stock.
Tango Therapeutics (NASDAQ:TNGX) had its target price lowered by Wedbush from $45.00 to $40.00. Wedbush currently has an outperform rating on the stock.
Tango Therapeutics (NASDAQ:TNGX) had its price target lowered by HC Wainwright from $68.00 to $67.00. They currently have a buy rating on the stock.
Tango Therapeutics (NASDAQ:TNGX) had its price target increased by JPMorgan Chase & Co. from $46.00 to $47.00. The firm currently has an overweight rating on the stock.
Toast (NYSE:TOST) had its price target boosted by Truist Financial from $38.00 to $40.00. They currently have a buy rating on the stock.
Turning Point Brands (NYSE:TPB) had its price target cut by Needham & Company LLC from $125.00 to $95.00. Needham & Company LLC currently has a buy rating on the stock.
Targa Resources (NYSE:TRGP) had its target price boosted by Scotiabank from $319.00 to $325.00. The firm currently has a sector outperform rating on the stock.
Targa Resources (NYSE:TRGP) had its target price raised by Morgan Stanley from $359.00 to $362.00. The firm currently has an overweight rating on the stock.
Trade Desk (NASDAQ:TTD) had its target price boosted by Morgan Stanley from $13.00 to $14.00. They currently have an equal weight rating on the stock.
Trade Desk (NASDAQ:TTD) had its price target boosted by Scotiabank from $12.00 to $15.00. They currently have a sector perform rating on the stock.
Trade Desk (NASDAQ:TTD) had its price target boosted by Guggenheim from $13.00 to $16.00. They currently have a neutral rating on the stock.
Trade Desk (NASDAQ:TTD) had its price target boosted by Royal Bank Of Canada from $15.00 to $18.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Trade Desk (NASDAQ:TTD) had its target price boosted by Rosenblatt Securities from $12.00 to $15.00. They currently have a neutral rating on the stock.
TWFG (NASDAQ:TWFG) had its target price raised by Morgan Stanley from $30.00 to $31.00. Morgan Stanley currently has an overweight rating on the stock.
Uniti Group (NASDAQ:UNIT) had its target price reduced by JPMorgan Chase & Co. from $11.00 to $9.00. The firm currently has a neutral rating on the stock.
Uniti Group (NASDAQ:UNIT) had its target price reduced by Wells Fargo & Company from $9.00 to $4.00. The firm currently has an equal weight rating on the stock.
Unum Group (NYSE:UNM) had its target price reduced by Morgan Stanley from $92.00 to $85.00. Morgan Stanley currently has an equal weight rating on the stock.
Ur Energy (NYSEAMERICAN:URG) (TSE:URE) had its target price reduced by HC Wainwright from $2.20 to $1.80. They currently have a buy rating on the stock.
USA Rare Earth (NASDAQ:USAR) had its price target reduced by Cantor Fitzgerald from $40.00 to $30.00. They currently have an overweight rating on the stock.
Vericel (NASDAQ:VCEL) had its target price increased by Stephens from $55.00 to $68.00. Stephens currently has an overweight rating on the stock.
Veracyte (NASDAQ:VCYT) had its price target trimmed by Piper Sandler from $54.00 to $30.00. They currently have an overweight rating on the stock.
Via Transportation (NYSE:VIA) had its target price increased by Citizens Jmp from $37.00 to $55.00. The firm currently has a market outperform rating on the stock.
Via Transportation (NYSE:VIA) had its target price raised by Guggenheim from $50.00 to $58.00. The firm currently has a buy rating on the stock.
Via Transportation (NYSE:VIA) had its target price increased by Wells Fargo & Company from $32.00 to $50.00. Wells Fargo & Company currently has an overweight rating on the stock.
Via Transportation (NYSE:VIA) had its target price boosted by Morgan Stanley from $33.00 to $48.00. They currently have an overweight rating on the stock.
Vir Biotechnology (NASDAQ:VIR) had its price target boosted by Morgan Stanley from $25.00 to $28.00. The firm currently has an overweight rating on the stock.
Virtus Investment Partners (NASDAQ:VRTS) had its target price boosted by Piper Sandler from $146.00 to $162.00. Piper Sandler currently has an overweight rating on the stock.
Welltower (NYSE:WELL) had its target price increased by JPMorgan Chase & Co. from $260.00 to $273.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Welltower (NYSE:WELL) had its price target increased by Royal Bank Of Canada from $260.00 to $266.00. The firm currently has an outperform rating on the stock.
WhiteHorse Finance (NASDAQ:WHF) had its price target raised by JPMorgan Chase & Co. from $6.50 to $7.50. They currently have an underweight rating on the stock.
Wix.com (NASDAQ:WIX) had its target price lowered by JPMorgan Chase & Co. from $62.00 to $59.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
TeraWulf (NASDAQ:WULF) had its price target reduced by Morgan Stanley from $65.00 to $47.00. The firm currently has an overweight rating on the stock.
TeraWulf (NASDAQ:WULF) had its price target lowered by Wells Fargo & Company from $30.00 to $22.00. They currently have an overweight rating on the stock.
Zeta Global (NYSE:ZETA) had its target price boosted by Royal Bank Of Canada from $40.00 to $41.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Zeta Global (NYSE:ZETA) had its target price raised by B. Riley Financial from $38.00 to $39.00. The firm currently has a buy rating on the stock.
ZOO Digital Group (LON:ZOO) had its price target boosted by Canaccord Genuity Group from GBX 22 to GBX 31. The firm currently has a buy rating on the stock.
Zura Bio (NASDAQ:ZURA) had its target price lowered by Oppenheimer to $5.00. Oppenheimer currently has an outperform rating on the stock.
Zymeworks (NASDAQ:ZYME) had its price target boosted by TD Cowen from $34.00 to $39.00. TD Cowen currently has a buy rating on the stock.
Zymeworks (NASDAQ:ZYME) had its target price boosted by Truist Financial from $35.00 to $36.00. They currently have a buy rating on the stock.
Zymeworks (NASDAQ:ZYME) had its target price raised by HC Wainwright from $55.00 to $56.00. The firm currently has a buy rating on the stock.
Receive News & Ratings for AAON Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAON Inc and related companies with MarketBeat.com's FREE daily email newsletter.
